Home › NDC Lookup › RxCUI directory › RxCUI 1191256

Fluocinolone acetonide 0.00025 MG/MG Topical Ointment — RxCUI 1191256

RxNorm drug concept · Semantic clinical drug
RxCUI 1191256 Semantic clinical drug · SCD ● Current RxNorm concept 5 FDA products 10 package NDCs Snapshot Jul 14, 2026

This page is curated, coded, and maintained by

Compiled from public NLM RxNorm and FDA (openFDA NDC directory) data sources. Editorial policy

What you’re looking at: the standardized identity of one medicine, as the U.S. drug-data system sees it. Below — every FDA-listed product, package code, price benchmark, and billing code that maps to it.

🗂️ Key Facts

RxCUI1191256
Official nameFluocinolone acetonide 0.00025 MG/MG Topical Ointment
Concept typeSemantic clinical drug (SCD)
RxNorm statusCurrent RxNorm concept
Also known asfluocinolone acetonide 0.025 % Topical Ointment
FDA products mapped5
Package NDCs mapped10
Reported Medicaid activity (SDUD)8,336 prescriptions · 18 state & territory Medicaid programs · latest period Q4 2025
RxNorm release07/06/2026
Snapshot dataJul 14, 2026

📖 Skip the Codes — Read It in Plain English.

Our pharmacist-built guide to Fluocinolone Topical: what it is, how it’s used, side effects, and interactions.

📗 Our plain-language guide HelloPharmacist
  • It's a prescription steroid cream applied to the skin to treat atopic dermatitis — what most people call eczema. It's approved for adults and for children as young as 3 months old....
  • What exactly is fluocinolone acetonide topical oil used for?
  • Apply a thin film to the affected areas using as little as you need to cover them. For adults, that's typically three times a day. For children, moisten the skin first, then apply...
  • How do I apply it correctly — and are there places I should avoid?
📖 Read our full Fluocinolone Topical guide →

🕸️ Concept Web — How Fluocinolone acetonide 0.00025 MG/MG Topical Oin... Connects

One RxCUI never lives alone. Follow the path from the raw ingredient down to the exact strength-and-form concepts FDA products carry — every stop is a real RxNorm concept with its own identifier. Hover or focus any chip for what it means.
This page's concept Fluocinolone acetonide 0.00025 MG/MG Topical Ointment RxCUI 1191256

Every web starts here: one RxCUI, one fixed meaning in the RxNorm vocabulary.

  1. Ingredients 2

    The active substance itself — no strength, form, or brand attached yet.

    • Fluocinolone 25126
    • Fluocinolone acetonide 4461
  2. Brand names 1

    The same medicine's trade names. A brand name alone says nothing about strength or form.

    • Synalar 224949
  3. Dose forms 9

    The ingredient poured into a form — tablet, solution, cream — still without one fixed strength.

    • Fluocinolone Topical Ointment 372221
    • Fluocinolone acetonide Topical Ointment 2647894
    • Fluocinolone Topical Product 1165646
    • Fluocinolone acetonide Topical Product 2661133
    • Fluocinolone Topical Ointment [Synalar] 367398
    • Fluocinolone acetonide Topical Ointment [Synalar] 2657637
    • Synalar Topical Product 1186047
    • Topical Ointment 316985
    • +1 more in this family
  4. Clinical & branded drugs 3

    Ingredient + strength + dose form. These are the concepts real FDA products actually carry.

Showing up to 8 concepts per family — 14 of 15 stored related concepts drawn.
These are official RxNorm vocabulary relationships — how concepts name and organize the same medicine. They do not establish therapeutic equivalence or substitutability: two concepts appearing in one web is never a statement that products can be swapped.

🔀 Generic ⇄ Brand Crosswalk

The same medicine has an unbranded (generic) identity and one or more brand-name identities — each with its own RxCUI. This is a naming relationship in RxNorm, not a statement that any two products are substitutable.

Generic (Clinical) Concepts

  • Fluocinolone acetonide 0.00025 MG/MG SCDC · 1191255
  • Fluocinolone Topical Ointment SCDF · 372221
  • Fluocinolone acetonide Topical Ointment SCDFP · 2647894
  • Fluocinolone Topical Product SCDG · 1165646
  • Fluocinolone acetonide Topical Product SCDGP · 2661133

Brand-Name Concepts

  • Fluocinolone acetonide 0.00025 MG/MG Topical Ointment [Synalar] SBD · 1191260
  • Fluocinolone acetonide 0.00025 MG/MG [Synalar] SBDC · 1191259
  • Fluocinolone Topical Ointment [Synalar] SBDF · 367398
  • Fluocinolone acetonide Topical Ointment [Synalar] SBDFP · 2657637
  • Synalar Topical Product SBDG · 1186047
  • Synalar BN · 224949

📦 FDA Products & Package NDCs

5 products · 10 package NDCs
10 package NDCs map to RxCUI 1191256 in the current snapshot — up to 50 per page. Each linked NDC opens its full package page.
Package NDC Package Brand / generic name Labeler Marketing start
00168-0064-15 15 g in 1 TUBE (0168-0064-15) Fluocinolone Acetonide E. Fougera & Co. a division of Fougera Pharmaceuticals, LLC 1982-12-16
00168-0064-60 60 g in 1 TUBE (0168-0064-60) Fluocinolone Acetonide E. Fougera & Co. a division of Fougera Pharmaceuticals, LLC 1982-12-16
00713-0223-15 1 TUBE in 1 CARTON (0713-0223-15) / 15 g in 1 TUBE Fluocinolone Acetonide Cosette Pharmaceuticals, Inc. 1988-07-26
00713-0223-60 1 TUBE in 1 CARTON (0713-0223-60) / 60 g in 1 TUBE Fluocinolone Acetonide Cosette Pharmaceuticals, Inc. 1988-07-26
00713-0224-15 1 TUBE in 1 CARTON (0713-0224-15) / 15 g in 1 TUBE Fluocinolone Acetonide Cosette Pharmaceuticals, Inc. 1988-07-26
00713-0224-60 1 TUBE in 1 CARTON (0713-0224-60) / 60 g in 1 TUBE Fluocinolone Acetonide Cosette Pharmaceuticals, Inc. 1988-07-26
43538-0910-12 1 TUBE in 1 CARTON (43538-910-12) / 120 g in 1 TUBE Synalar Medimetriks Pharmaceuticals, Inc. 2012-09-27
43538-0910-99 6 TUBE in 1 CARTON (43538-910-99) / 3 g in 1 TUBE Synalar Medimetriks Pharmaceuticals, Inc. 2012-09-27
62559-0299-15 1 TUBE in 1 CARTON (62559-299-15) / 15 g in 1 TUBE Fluocinolone Acetonide ANI Pharmaceuticals, Inc. 2023-11-16
62559-0299-60 1 TUBE in 1 CARTON (62559-299-60) / 60 g in 1 TUBE Fluocinolone Acetonide ANI Pharmaceuticals, Inc. 2023-11-16
Observed labelers: Cosette Pharmaceuticals, Inc. (4) · ANI Pharmaceuticals, Inc. (2) · E. Fougera & Co. a division of Fougera Pharmaceuticals, LLC (2) · Medimetriks Pharmaceuticals, Inc. (2) — this is the FDA-listed mapping footprint, not sales, inventory, availability, or market share.

🗃️ Sources & Limits

Atlas generation902fddb9-e9c1-4004-bf4c-dba4d51037c7
openFDA export observedJul 14, 2026
RxNorm release07/06/2026
Methodology2026-07-full-catalog-v1
  • A shared RxCUI does not prove interchangeability. Products mapped to the same concept are not thereby equivalent or substitutable — equivalence is a separate, product-level determination.
  • Listing here does not establish approval or coverage. Appearing in this snapshot is a data observation, not an FDA approval status or a payer coverage decision.
  • Missing data never means zero. A silent dataset (no price, no billing code, no utilization) means no observation — not that the real-world value is zero.
  • Counts describe the mapping footprint. Product, package, and labeler counts are the FDA-listed mapping footprint in this snapshot — not sales, inventory, availability, or market share.
This product uses publicly available data from the U.S. National Library of Medicine (NLM), National Institutes of Health, Department of Health and Human Services; NLM is not responsible for the product and does not endorse or recommend this or any other product.

Machine-readable JSON

Reference information about drug-concept identifiers and public regulatory data — not medical advice. Talk to your pharmacist or prescriber about your own medication.